Act for the Development of Biotech and Pharmaceutical Industry Article 7
To encourage the establishment or expansion of Biotech and Pharmaceutical Companies, a profit-seeking enterprise that (i) originally subscribes for or underwrites shares issued by a Biotech and Pharmaceutical Company; and (ii) has been a registered shareholder of the Biotech and Pharmaceutical Company for a period of three (3) years or more, may, for a period of five (5) years from the first year it incurs profit-seeking enterprise income tax liability, enjoy a reduction in its profit-seeking enterprise income tax payable by up to twenty percent (20%) of the total amount of price paid for the subscription of the shares in such Biotech and Pharmaceutical Company; provided that such Biotech and Pharmaceutical Company has not applied for exemption from profit-seeking enterprise income tax or shareholder investment credit based on the subscription price under any other laws. The total amount creditable in each year shall not exceed fifty percent (50%) of the profit-seeking enterprise income tax payable in the then-current year.Where the Biotech and Pharmaceutical Company described in the preceding paragraph engages in the business activities described in Item (ii), Subparagraph 2, Paragraph 1, Article 4 hereof, it is eligible for the tax credit hereunder only if it is not listed on the Taiwan Stock Exchange and the Taipei Exchange, or is a company listed on the Taiwan Stock Exchange or the Taipei Exchange but was incorporated and registered less than ten (10) years ago.If the profit-seeking enterprise described in Paragraph 1 is a venture capital company (“VC”), its corporate shareholders may, for a period of five years from the fourth anniversary of the date on which the VC becomes a registered shareholder of the subject Biotech and Pharmaceutical Company, enjoy a reduction in their profit-seeking enterprise income tax payable based on the total deductible amount enjoyed by the VC under Paragraph 1 hereof and the shareholders' respective shareholdings in the VC. The total amount creditable in each year shall not exceed fifty percent (50%) of the profit-seeking enterprise income tax payable in the then-current year.With respect to the investment tax credit applicable to the shareholders of the profit-seeking enterprises described in Paragraph 1 hereof and the VCs described in the preceding paragraph, the requirements, deadline for filing applications, application procedures, valid period, tax credit rate and other relevant matters shall be prescribed by the Competent Authority in conjunction with the Ministry of Finance.
中文原文 生技新藥產業發展條例第7條
為鼓勵生技醫藥公司之創立或擴充,營利事業原始認股或應募屬該生技醫藥公司發行之股票,成為該公司記名股東達三年以上,且該生技醫藥公司未以該認股或應募金額,依其他法律規定申請免徵營利事業所得稅或股東投資抵減者,得以其取得該股票之價款百分之二十限度內,自其有應納營利事業所得稅之年度起五年內抵減各年度應納營利事業所得稅額。
其每一年度得抵減總額,以不超過該營利事業當年度應納營利事業所得稅額百分之五十為限。
前項所定生技醫藥公司,屬從事第四條第一項第二款第二目業務者,以未上市、未上櫃公司,或自設立登記日起未滿十年之上市、上櫃公司為限。
第一項營利事業如為創業投資事業,應由其營利事業股東按該創業投資事業依該項規定原可抵減之金額,依其持有該創業投資事業股權比例計算可享投資抵減金額,自創業投資事業成為該生技醫藥公司記名股東第四年度起五年內抵減各年度應納營利事業所得稅額。
其每一年度得抵減總額,以不超過該營利事業當年度應納營利事業所得稅額百分之五十為限。
第一項營利事業及前項創業投資事業適用股東投資抵減之要件、申請期限、申請程序、施行期限、抵減率及其他相關事項之辦法,由主管機關會同財政部定之。
其每一年度得抵減總額,以不超過該營利事業當年度應納營利事業所得稅額百分之五十為限。
前項所定生技醫藥公司,屬從事第四條第一項第二款第二目業務者,以未上市、未上櫃公司,或自設立登記日起未滿十年之上市、上櫃公司為限。
第一項營利事業如為創業投資事業,應由其營利事業股東按該創業投資事業依該項規定原可抵減之金額,依其持有該創業投資事業股權比例計算可享投資抵減金額,自創業投資事業成為該生技醫藥公司記名股東第四年度起五年內抵減各年度應納營利事業所得稅額。
其每一年度得抵減總額,以不超過該營利事業當年度應納營利事業所得稅額百分之五十為限。
第一項營利事業及前項創業投資事業適用股東投資抵減之要件、申請期限、申請程序、施行期限、抵減率及其他相關事項之辦法,由主管機關會同財政部定之。